title: Prevalence of atopic disorders in rheumatic diseases.
abstract: OBJECTIVE
  The aim of this study was to assess the point prevalences of hay fever, asthma, and atopic dermatitis in OA, RA, and AS, and to compare with healthy controls.
  
  
  METHODS
  A total of 935 patients and healthy controls were included. Demographic and clinical features were recorded, and a questionnaire assessing the existence of atopic disorders like asthma, hay fever, and atopic dermatitis in all groups was applied. "Either atopy" implied that an individual was either diagnosed with or had symptoms of one or more of these disorders, such as asthma, hay fever, or atopic dermatitis.
  
  
  RESULTS
  When compared to the controls, only patients with AS had an increased risk for hay fever (OR 1.52, 95 % CI 1.00-2.41). Patients with RA had increased risks for hay fever, atopic dermatitis, and either atopy compared to the patients with OA (2.14, 95 % CI 1.18-3.89; 1.77, 95 % CI 1.00-3.18; and 3.45, 95 % CI 1.10-10.87, respectively). Steroid use had no effect on the prevalence of atopic disorders in patients with RA.
  
  
  CONCLUSIONS
  Patients with OA, RA, and AS seem to have similar risks for asthma, atopic dermatitis, and either atopy to healthy controls. However, the prevalence of hay fever may increase in AS. Patients with RA have a higher risk of atopy than patients with OA.
authors.affiliation: Department of Physical Medicine and Rehabilitation, Medical Faculty, Ataturk University, 25240 Erzurum, Turkey. skaratay73@gmail.com
authors.forename: Saliha
authors.initials: S
authors.lastname: Karatay
authors.forename: Kadir
authors.initials: K
authors.lastname: Yildirim
authors.forename: Mahir
authors.initials: M
authors.lastname: Ugur
authors.forename: Kazim
authors.initials: K
authors.lastname: Senel
authors.forename: Akin
authors.initials: A
authors.lastname: Erdal
authors.forename: Bekir
authors.initials: B
authors.lastname: Durmus
authors.forename: Ozlem
authors.initials: O
authors.lastname: Baysal
authors.forename: Zuhal
authors.initials: Z
authors.lastname: Altay
authors.forename: Aysegul Jale
authors.initials: AJ
authors.lastname: Sarac
authors.forename: Ali
authors.initials: A
authors.lastname: Gur
authors.forename: Ozge
authors.initials: O
authors.lastname: Ardicoglu
authors.forename: Ayhan
authors.initials: A
authors.lastname: Kamanli
authors.forename: Remzi
authors.initials: R
authors.lastname: Cevik
authors.forename: Arzu
authors.initials: A
authors.lastname: Kaya
authors.forename: Yuksel
authors.initials: Y
authors.lastname: Ersoy
authors.forename: Kemal
authors.initials: K
authors.lastname: Nas
authors.forename: Salih
authors.initials: S
authors.lastname: Ozgocmen
mesh_terms: D000328:Adult; D000368:Aged; D001249:Asthma / Q000453:epidemiology*; D015897:Comorbidity; D003876:Dermatitis, Atopic / Q000453:epidemiology*; D005260:Female; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000453:epidemiology*; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D012216:Rheumatic Diseases / Q000453:epidemiology*; D006255:Rhinitis, Allergic, Seasonal / Q000453:epidemiology*; D012307:Risk Factors; D011795:Surveys and Questionnaires